Obamacare’s future under Trump administration
Laffer on Obamacare’s future, HHS Secretary
Nissan banks on after-sales 'hyper-personalization' revenue
Nissan is going to offer internet access, safety technology and myriad accessory options the Japanese automaker calls "hyper-personalization," not only in new models but also for vehicles people already own.
Millennials Need to Worry About Alzheimer's, Too
Doctors warn that with no cure or prevention treatments available, millennials should be just as concerned about the disease as older adults.
Sen. Warren blasts drug approval bill as 'extortion'
Massachusetts Sen. Elizabeth Warren says a bill providing extra money for medical research is "extortion" and a giveaway to big biomedical companies.
Is There a Merger Rift Between Anthem and Cigna?
Newly unsealed court testimony shows revealing new details about a rift that is highly unusual for two companies pressing ahead with a merger request.
UnitedHealth backs 2016 views, issues 2017 guidance
UnitedHealth is backing its 2016 financial guidance and expects growth into 2017, with earnings per share potentially reaching $9.60.
UnitedHealth Gives Investors Some Good News, Shares Pop
UnitedHealth Group gave investors an early holiday gift.
Changemakers: One Startup Revolutionizing the Medical Marijuana Industry
The cannabis industry has been growing drastically in the past five years, with revenue expected to hit $6.7 billion in 2016.
What Trump can learn from Obama's rough ride on health care
President Barack Obama took on the problems of a lack of access to health care and high cost, but he and Democrats paid a political price.
Report: J&J Approaches Swiss Drugmaker Actelion
U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover.
Markets Right Now: US indexes open mostly lower
The latest on developments in financial markets (All times local): 9:35 a.m.
Eli Lilly shares plunge as Alzheimer’s drug fails trial
Eli Lilly Alzheimer’s drug
Eli Lilly abandons Alzheimer's drug after trial failure
Eli Lilly abandons Alzheimer's drug
Kia recalls about 72K SUVs; electric short can cause fires
Kia is recalling nearly 72,000 SUVs in the U.S. because an electrical short in a computer can cause engine fires.
Juno Says Two More Patients Die in Leukemia Drug Trial; Stock Sinks
Juno Therapeutics Inc said two more patients had died after suffering brain swelling during a trial of its experimental genetically engineered leukemia drug, bringing the total up to five.
The Four Companies That Sent the Dow to 19000
Shares of banks, industrials and health-care companies propelled the Dow Jones Industrial Average to 19000 on Tuesday.
Lilly Alzheimer's Drug Fails to Slow Memory Loss, Shares Plunge
Eli Lilly's experimental drug solanezumab failed to slow loss of cognitive ability in patients with mild Alzheimer's disease in a large trial.
Medtronic beats 2Q profit forecasts
Medtronic PLC (MDT) on Tuesday reported fiscal second-quarter net income of $1.12 billion.
Toyota recalling 834,000 Sienna minivans in North America
Toyota Motor Corp. is recalling 834,000 Toyota Sienna minivans in North America because the sliding doors could open while the vehicle is moving.
Intraparty Dissent Could Turn Trump Into a 'Sell Out'
President-elect Trump’s party may control of the executive and legislative branches, but not everyone believes unified Republican rule will follow. In fact, some predict any pretense of GOP unity will disappear quite early in 2017.

















